CNEN

Welcome to Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.!

Search

Copyright:  Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.!   京ICP备19006400号-1​     Powered by 300.cn

美科

Links:

Stemedica Cell Technologies, Inc., a US company with investment from JZT, received US FDA approval of its application for a Phase II clinical trial treating COVID-19 patients with MSCs.

Source:
Release time:
2020/09/27 14:11
Page view

Stemedica Cell Technologies, Inc., a US company with investment from JZT, received US FDA approval of its application for a Phase II clinical trial treating COVID-19 patients with MSCs.